Amneal Reporings $45M in New Term Loans for Refinancing
Amneal Pharmaceuticals entered into Amendment No. 3 to its Term Loan Credit Agreement, adding $45.2 million in new term loans to refinance outstanding Amendments 2 loans and make further credit facility amendments.
View filing at SEC.gov →